bananas start-up CRISPR has raised 50bn in an oversubscribed series A funding round led by Five Seasons Ventures and Five Seasons Ventures . In addition, Five Seasons' Ben Belldegrun and Niccolo Manzoni join the company's board. Tropic is developing disease-resistant bananas and coffee with little or no caffeine levels using gene-editing technology, including Tropic Biosciences . The company aims to sell young plants and licence its proprietary genetics to other growers. In coffee, Tropic is prioritizing turning off genes that develop the caffeine in coffee, creating a decaffeinated or nearly-decaffeinated coffee that doesn’t require the extensive processing — both chemical and heat — used to remove caffeine today. The global combined market for bananas and coffee is valued at $ 50bn .
bananas start-up CRISPR has raised 50bn in an oversubscribed series A funding round led by Five Seasons Ventures and Five Seasons Ventures . In addition, Five Seasons' Ben Belldegrun and Niccolo Manzoni join the company's board. Tropic is developing disease-resistant bananas and coffee with little or no caffeine levels using gene-editing technology, including Tropic Biosciences . The company aims to sell young plants and licence its proprietary genetics to other growers. The global combined market for bananas and coffee is valued at $ 50bn .